Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors.
Journal: Journal of medicinal chemistry
Published: December 12, 2023
Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.
Journal: Journal of medicinal chemistry
Published: April 18, 2022
Fragment-Based Discovery of Small Molecules Bound to T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (TIM-3).
Journal: Journal of medicinal chemistry
Published: October 01, 2021
Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core.
Journal: Journal of medicinal chemistry
Published: December 21, 2019
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer.
Journal: Journal of medicinal chemistry
Published: April 02, 2019
Fragment-based screening of programmed death ligand 1 (PD-L1).
Journal: Bioorganic & medicinal chemistry letters
Published: November 29, 2018
Showing 1-6 of 6
Last Updated: 09/26/2026